Skip to main content
Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie logoLink to Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie
. 2022 Oct 31;68(3):163–177. doi: 10.1177/07067437221136461

Predictors of Death From Physical Illness or Accidental/Intentional Causes Among Patients With Substance-Related Disorders

Prédicteurs de décès d'une maladie physique ou de causes accidentelles/intentionnelles chez des patients souffrant de troubles liés à des substances

Marie-Josée Fleury 1,, Zhirong Cao 2, Guy Grenier 2, Christophe Huỳnh 3
PMCID: PMC9974654  PMID: 36317322

Abstract

Objective

This study identified patient clinical and sociodemographic characteristics, and, more originally, service use patterns as predictors of death from physical illness or accidental/intentional causes.

Methods

A cohort of 19,015 patients with substance-related disorders (SRD) from 14 addiction treatment centers was investigated using Quebec (Canada) health administrative databases. Death was studied over a 3-year period (April 1, 2013, to March 31, 2016), and most predictors from 4 years to 12 months prior to the time of death, using multinomial logistic regression.

Results

Frequent emergency department (ED) use strongly predicted both causes of death, suggesting that outpatient care responded inadequately to patient needs. Only receipt of specialized SRD and psychiatric care significantly decreased the risk of death from physical illness, with trends toward significance for accidental/intentional death. Hospitalization, greater material deprivation and having SRD-chronic physical illnesses or alcohol-related disorders most strongly predicted risk of death from physical illness. Sociodemographic characteristics, mainly social deprivation, were more likely to predict accidental/intentional death.

Conclusions

Outpatient services could be improved by increasing outreach and motivational interventions and, for ED and hospital units, better screening, brief intervention, and referral to treatment, particularly for men and socially deprived patients at high risk of accidental/intentional death. Patients with more severe health conditions, notably older or materially deprived men at higher risk of death from physical illness, could benefit from programs like assertive community treatment or intensive case management that respond well to diverse and continuous patient needs. Collaborative care between SRD and health services could also be improved.

Keywords: substance-related disorders, death, physical illness, accidental or intentional causes, predictors, service use.

Introduction

Substance-related disorders (SRD) are the main cause of death worldwide.1,2 Estimates of potential life lost were 21.6 years for individuals with SRD and 23.2 years for those with cooccurring SRD-mental disorders (MD) in a 2010 to 2017 US study, 3 and 24 to 28 years for individuals with alcohol-related disorders in a 1987 to 2006 study conducted in Nordic countries. 4 European patients treated for SRD in 2012−2013 had a 10 to 20 times higher risk of death than the general population, controlling for age and sex. 5 Patients treated for opioids, cocaine, cannabis, or alcohol-related disorders were identified as having a much greater risk of death, that is, 15 to 20,5,6 six, 7 five, 8 and four times higher, respectively, 9 compared to patients without SRD. SRD also increased the risks for chronic physical illnesses, including cancer, cardiovascular or respiratory diseases, and HIV/AIDS. 5 A 2014 systematic review and meta-analysis found that patients with alcohol-related disorders had a 10 times greater risk of dying from cirrhosis of the liver and twice the risk for cancer or cardiovascular diseases than the general population. 10 SRD also increased the risk of accidental death (e.g., car accidents and drowning) or intentional death (e.g., suicide and self-harm). 5 Death by suicide is reportedly high among patients with SRD.11,12 Despite their elevated risk of premature death, most patients with SRD (fewer than 20% in the US 13 ) lacked access to specialized treatment.9,14

Several studies have assessed death among patients with SRD over a period ranging from 215-17 to 42 years. 18 Most focused on specific substances, mainly opioids,15,19-21 but also alcohol, 10 cocaine, 22 and cannabis-related disorders. 8 These studies investigated death from any cause16,19,23 or by overdose/intoxication15,17,24 or suicide,25-27 whereas few assessed death due to overdose/intoxication versus physical illness.15,18 Previous hospitalization was associated with both death from any cause 19 and overdose/intoxication more specifically, 24 while having chronic physical illnesses 23 and older age 15 increased the overall risk of death from physical illness. Having polysubstance-related disorders17,18 was associated with death by overdose/intoxication and physical illness. The number of years with SRD 23 related to death overall, whereas younger age related to death by overdose/intoxication 18 and suicide. 25 Living alone, 24 injection drug use, 24 previous nonfatal overdose, 17 and co-occurring SRD-MD 18 were mainly associated with death by overdose/intoxication, whereas retention in SRD treatment 21 decreased this risk. Disrupted relationships, unemployment, childhood abuse, previous suicide attempts, 27 chronic alcohol and opioid-related disorders,25,26 and MD 27 were mainly linked to death by suicide.

This study is original as it examines death in a large cohort of patients with SRD who used addiction treatment centers and compares predictors of death from physical illness and accidental/intentional death. In Quebec, addiction treatment centers serve roughly 10% of the population with SRD, 28 representing highly vulnerable patients. Particular attention was given to patient service use patterns up to the time of death, as service use has rarely been explored as a predictor of death. Considering that adverse outcomes vary over time and according to SRD, we hypothesized that death from physical illness would be more strongly predicted by severe health conditions among patients than accidental/intentional death. We also hypothesized that more adequate outpatient service use would protect against both deaths from physical illness and accidental/intentional causes. This study thus aimed to identify patient clinical and sociodemographic characteristics, and their service use patterns predicting death from physical illness or accidental/intentional death, compared to patients with SRD who did not die during the study period. More comprehensive identification of predictors of death from physical illness versus accidental/intentional death could help strengthen targeted interventions to reduce the overall risk of death among patients with SRD.

Methods

Study Context

Quebec addiction treatment centers are specialized regional organizations offering SRD programs like detoxification, substitution treatment and rehabilitation, including brief intervention units, accessible through self-referral, referral from primary care or court order. Addiction treatment centers are complementary to primary care provided by general practitioners (GP), most of whom work in family medicine groups, or by psychosocial teams operating in community healthcare centers. Family medicine groups include psychosocial staff (e.g., social workers), require patient registration and provide extended medical coverage, aiming to ensure continuity of patient care.

Study Sample, Sources, and Design

Data were collected in the financial year 2012–2013 (April 1−March 31) for a cohort of 19,099 patients who used one of 14 (out of 16) Quebec addiction treatment centers. Patients had to be Quebec residents, 12 + years old, registered in the addiction treatment center database (SIC-SRD), and eligible for the Quebec Health Insurance Plan (Régie de l’assurance maladie du Québec, RAMQ) between 1996−1997 and 2015−2016. Patients were excluded if they died during 2012−2013, or if their cause of death was unknown. Data from SIC-SRD included patient sociodemographic characteristics, type of SRD and services received in these centers. The RAMQ integrated billing systems of physician services, except for 6% of services occurring outside the public system. 29 The RAMQ also included various subdatabases concerning hospitalization, emergency department (ED) use, psychosocial interventions in community healthcare centers and causes of death. Diagnostic codes from RAMQ were framed by the International Classification of Diseases, Ninth and Tenth Revisions (Appendix 1). The SIC-SRD integrated standardized instruments which measured the presence of SRD (yes/no), based on the Addiction Severity Index 30,31 or the Global Appraisal of Individual Needs. 32

Death was measured for a 3-year period, from 2013−2014 to 2015−2016. Predictors of death included patient clinical characteristics measured from 2012−2013 to 2015−2016 or to the time of death, except for the number of years with SRD measured from 1996−1997 to 2015−2016 or to the time of death. Patient sociodemographic characteristics were measured in the year of death and services use 12 months prior to death, except for the variables on criminal history or history of homelessness, measured from 2009–2010 to 2015−2016 or to time of death. For these measures, a case-control design was used: each living patient was allocated an exposure window in the same way as a randomly selected patient of the same age and sex who died between 2013−2014 and 2015−2016. Figure 1, the study framework, identifies all databases linked to each study variable, including their measurement intervals. Data from all the databases were merged yearly, for each patient, through a unique RAMQ identifier matched with the SIC-SRD database (100% data linkage). Access to the databases was granted by the Quebec Commission for Access to Information, and the ethics review board of the Integrated University Health and Social Services Center of the South-Central Island of Montreal approved the study protocol.

Figure 1.

Figure 1.

Framework: predictors of death from physical illness or accidental/intentional causes among patients with substance-related disorders.

a Régie de l’assurance maladie du québec (RAMQ, physician claims database); b Banque de données communes des urgences (BDCU, Ed database); c Maintenance et exploitation des données pour l’étude de la clientèle hospitalière (MED-ECHO, Hospital inpatient and Day Surgery database); d Système d’information clientèle pour les services de réadaptation dépendances (SIC-SRD, addiction treatment center database, including SRD and behavioral addictions based on standardized instruments); e Système d’information permettant la gestion de l’information clinique et administrative dans le domaine de la santé et des services sociaux (I-CLSC, Psychosocial Interventions in Community Healthcare centers, including GP working on salary); f Fichier d’inscription des personnes assurées (FIPA, Health Insurance Registry); g Fichier des décès du registre des évènements démographiques (RED, vital statistics death database). * Each living patient was allocated an exposure window in the same way as a randomly selected patient of the same age and sex who died between 2013–14 and 2015–16 (see Methods section). For definitions of the variables in the study see footnotes in Table 1 or the Methods section. Details on diagnostic codes and instruments are presented in Appendix 1.

Variables

Three groups were compared on the outcome variable: death from physical illness (e.g., cancer and cardiovascular diseases), accidental death (e.g., motor vehicle accident and falls) or intentional death (e.g., self-harm and suicide—see Appendix 1), and “no death” used as the reference group. Patient clinical characteristics included type of SRD, number of years with SRD, principal MD, chronic physical illnesses (yes/no; severity), cooccurring SRD-MD-chronic physical illnesses, and suicidal behaviours (suicide ideation and attempt). SRD referred to alcohol and drug use disorders, intoxication, induced disorders, and withdrawal. Type of SRD included alcohol-related disorders only, and other SRD. Alcohol-related disorders only were distinguished from other SRD, as being the most prevalent substance in the US 33 and often used without drugs. 34 Principal MD included serious MD (schizophrenia spectrum and other psychotic disorders, bipolar disorders), personality disorders, and common MD (e.g., anxiety and depressive disorders). Chronic physical illnesses, based on an adapted version of the integrated Elixhauser and Charlson Comorbidity Indexes, 35 comprised the number and level of illness severity per patient from 0 to 3+.

Patient sociodemographic characteristics encompassed sex, age group (˂50, 50+ years), living situation (e.g., alone or single parent), principal occupation (e.g., student or worker), material and social deprivation, type of residential area (e.g., urban), criminal history, and history of homelessness. The 50-year threshold was determined based on an adult's developmental perspective, where middle-aged adulthood (50 to 64 years old) usually begins.36,37 This period also coincides with menopause in women, and a higher prevalence of chronic illnesses, especially cardiovascular illnesses.38,39 The Material Deprivation Index, based on the smallest dissemination areas established for the 2011 Canadian census, integrated ratios of population employment, average income, and education levels lower than high school, while the Social Deprivation Index included proportions of patients living alone, those whose civil status is “single,” and single-parent families. 40 Both indexes were classified in quintiles but were regrouped for this study as less deprived (1 to 3) and more deprived (4 to 5 and not assigned—e.g., homelessness) areas.

Patient service use variables included usual outpatient physician (usual GP or psychiatrist only, both usual GP and psychiatrist), number of consultations with usual GP or psychiatrist, high continuity of physician care, psychosocial interventions received in community healthcare centers, number of interventions provided for any SRD in addiction treatment centers, frequent ED use and hospitalization for any medical reason. Usual GP, a proxy for family doctor, was defined as having at least 2 consultations with the same GP working in a private clinic or community healthcare center, or with at least 2 GP working in the same family medicine group. Usual psychiatrist was defined as one who followed a patient in outpatient care at least twice. Alternatively, patients who made only 1 consultation with a psychiatrist had to have consulted their GP at least twice, which was a proxy for collaborative care. 41 Highest frequency of care was defined as receiving at least 4+ consultations or interventions/year.42-44 Continuity of physician care was measured with the Usual Provider Continuity Index, describing the proportion of consultations with the usual GP or psychiatrist of all GP and psychiatrists consulted in outpatient care, including consultations in walk-in clinics. A score of ≥0.80 is considered high continuity of care. 45 Frequent ED use was defined as 4+ visits/year, which is a minimum standard.46,47

Analyses

As missing values were <1%, a complete case analysis was used. 48 Descriptive analyses followed by bivariate multinomial logistic regressions were produced, the latter testing associations between each independent variable and the outcome variable (death). As the intraclass correlation coefficient was small (0.02), indicating low shared variance among patients from the 14 addiction treatment centers, multilevel analysis was not required, but is usually recommended for 50+ level 2 analysis units.49,50 Predictors identified as significant in bivariate analyses (Alpha: 0.20) 51 were entered with the forward stepwise model selection into the multivariable multinomial logistic regression model, with “no death” as the reference group. This model was justified considering the low number of death events, despite the large study sample. The Akaike Information Criterion (AIC) 52 was used to select the final multivariate model, including the smallest AIC. Variance inflation factor (VIF) was also tested, and small VIF values (<3) indicate a low correlation among variables. 53 Relative risk ratio (RRR) and 95% confidence interval (CI) were calculated in the final model. Statistical analyses were performed using Stata 17. 54

Results

Of the 19,099 patients with SRD, 74 deceased in 2012−2013 and 10 died of unknown causes from 2013−2014 to 2015−2016, who were excluded. Of the final 19,015-patient sample, 255 (1.3%) died from physical illness and 199 (1.1%) of accidental/intentional causes from 2013−2014 to 2015−2016. Patients included 20% with alcohol-related disorders only, 73% had MD (38% common MD and 24% serious MD), 42% chronic physical illnesses, 34% cooccurring SRD-MD-chronic physical illnesses, and 16% suicidal behaviours (Table 1). The majority (66%) were men, 19% were 50+ years, 55% were unemployed or retired, 46% lived alone, 57% and 52% were in more materially or socially deprived areas, and 52% were in urban areas. Within the 12-month period prior to death, 44% of patients were without a usual physician, 49% consulted their usual GP and 19% their usual psychiatrist, with 46% receiving high continuity of physician care; 44% were provided with psychosocial interventions in community healthcare centers, and 55% services from addiction treatment centers. About half (51%) used ED, including 9% who were frequent ED users, and 20% were hospitalized.

Table 1.

Characteristics of Patients with SRD.

No death Death from physical illness* Death from accidental or intentional causes* Total Bivariate analysis
n % n % n % n % P-value
Group size (N = 19,015 or other as specified) 18,561 97.61 255 1.34 199 1.05 19,015 100.00
Patient clinical characteristics (measured from April 1, 2012, to March 31, 2016; to time of death; or other if specified)
Type of SRD <.001
 Alcohol-related disorders only 3,625 19.53 103 40.39 36 18.09 3,764 19.79
 Other SRD 14,936 80.47 152 59.60 163 81.91 15,251 80.21
Number of years with SRD (measured from April 1, 1996–1997 to March 31, 2015–2016 or to time of death) <0.001
 1–2 8,456 45.56 48 18.82 46 23.12 8,550 44.96
 3–5 5,710 30.76 88 34.51 65 32.66 5,863 30.83
 6+ 4,395 23.68 119 46.67 88 44.22 4,602 24.20
Principal MD a <0.001
 Serious MD a 4,447 23.96 82 32.16 67 33.67 4,596 24.17
 Personality disorders 2,174 11.71 36 14.12 31 15.58 2,241 11.79
 Common MD a 6,982 37.62 92 36.08 64 32.16 7,138 37.54
 No MD 4,958 26.71 45 17.65 37 18.59 5,040 26.51
Chronic physical illnesses b 7,613 41.02 241 94.51 121 60.80 7,975 41.94 <0.001
Severity of chronic physical illnesses <0.001
 0 15,118 81.45 132 51.76 163 81.91 15,413 81.06
 1 1,105 5.95 4 1.57 4 2.01 1,113 5.85
 2 1,258 6.78 36 14.12 15 7.54 1,309 6.88
 3+ 1,080 5.82 83 32.55 17 8.54 1,180 6.21
Cooccurring SRD-MD-chronic physical illnesses 6,247 33.66 202 79.22 103 51.76 6,552 34.46
Suicidal behaviours (suicide ideation or attempt) 2,916 15.71 32 12.55 65 32.66 3,013 15.85 <0.001
Patient sociodemographic characteristics (measured in the year of death or other if specified) c
Men 12,130 65.35 201 78.82 148 74.37 12,479 65.63 <0.001
Older people (50+ years) 3,354 18.07 155 60.78 46 23.12 3,555 18.70 <0.001
Living situation: alone or single parent (vs. in couple, with relatives or friends) (N = 17,133) 7,636 45.67 166 72.49 111 60.33 7,913 46.19 <0.001
Principal occupation: unemployed or retired (vs. student or worker) 10,016 53.96 220 86.27 144 72.36 10,380 54.59 <0.001
Living in more materially deprived areas (4, 5 or not assigned) d 10,395 56.00 219 85.88 163 81.91 10,777 56.68 <0.001
Living in more socially deprived areas (4, 5 or not assigned) d 11,494 61.93 219 85.88 179 89.95 11,892 62.54 <0.001
Type of residential areas (N = 18,997) 0.001
Urban (≥100,000) 9,628 51.92 151 59.21 110 55.28 9,889 52.05
Semi-urban (10,000 to 99,999) 5,400 29.12 55 21.57 39 19.60 5,494 28.92
Rural (<10,000) 3,515 18.96 49 19.22 50 25.13 3,614 19.02
Criminal history with/without incarceration (measured from April 1, 2009, to March 31, 2016, or to the time of death) 3,558 19.17 39 15.29 44 22.11 3,641 19.15 0.167
History of homelessness (measured from April 1, 2009, to March 31, 2016, or to the time of death) 2,481 13.37 47 18.43 32 16.08 2,560 13.46 0.035
Patient service use (measured within 12 months prior to death) c
Usual outpatient physician e 0.002
 Usual GP only 6,860 36.96 114 44.71 73 36.68 7,047 37.06
 Usual psychiatrist only 1,347 7.26 12 4.71 12 6.03 1,371 7.21
 Both GP and psychiatrist 2,162 11.65 29 11.37 39 19.60 2,230 11.73
 No usual physician 8,192 44.14 100 39.22 75 37.69 8,367 44.00
Number of consultations with usual GP e 0.003
 0–1 9,539 51.39 112 43.92 87 43.72 9,738 51.21
 2–3 4,371 23.55 61 23.92 45 22.61 4,477 23.54
 4+ 4,651 25.06 82 32.16 67 33.67 4,800 25.24
Number of consultations with usual psychiatrist e 0.058
 0 15,052 81.09 214 83.92 148 74.37 15,414 81.06
 1–3 1,634 8.80 20 7.84 28 14.07 1,682 8.85
 4+ 1,875 10.10 21 8.24 23 11.56 1,919 10.09
High continuity of physician care, integrating both usual GP and psychiatrist (≥0.80) f 8,462 45.59 131 51.37 88 44.22 8,681 45.65 0.169
Psychosocial interventions received in community healthcare centers (excluding GP consultations) g 8,170 44.02 167 65.49 117 58.80 8,454 44.46 <0.001
Number of interventions provided through any treatment program in addiction treatment centres h 0.138
 0 8,413 45.33 127 49.80 86 43.22 8,626 45.36
 1–3 2,967 15.99 40 15.69 43 21.61 3,050 16.04
 4+ 7,181 38.69 88 34.51 70 35.18 7,339 38.60
Number of ED use for any medical reason <0.001
 0 9,306 50.14 27 10.59 42 21.11 9,375 49.30
 1–3 7,732 41.66 119 46.67 96 48.24 7,947 41.79
 4+ 1,523 8.21 109 42.75 61 30.65 1,693 8.90
Hospitalizations for any medical reason 3,469 18.69 215 84.31 103 51.76 3,787 19.92 <0.001

Note. SRD = substance-related disorders; MD = mental disorders; GP = general practitioner; ED = emergency department.

*Death was measured from April 1, 2013, to March 31, 2016; 3-year period; financial year, April 1–March 31.

a

MD are organized in hierarchical groups, from the most serious MD to no MD. For example, if a patient had both a serious MD and common MD, this patient would be classified under serious MD. Serious MD included: schizophrenia spectrum and other psychotic disorders, bipolar disorders; common MD included: anxiety disorders, depressive disorders, adjustment disorders and other common MD.

b

Chronic physical illnesses included: renal failure, cerebrovascular illnesses, neurological illnesses, endocrine illnesses, tumours without or with metastasis, chronic pulmonary illnesses, diabetes complicated and uncomplicated, cardiovascular illnesses, and other chronic illness categories (e.g., blood loss anemia) (see Appendix 1).

c

Each patient in the “no death” group was allocated an exposure window in the same way as a randomly selected patient of the same age and sex who died between 2013–2014 and 2015–2016 (see the “Methods” section).

d

Material and social deprivation indices are related to the smallest residential dissemination areas, based on the 2011 Canadian census. For this study, the quintiles were regrouped into 2 levels representing the less (1–3) and more (4–5, or not assigned) deprived areas. “Not assigned” areas related to missing addresses or living in an area where index assignment was not feasible. An index cannot usually be assigned to residents of nursing homes or to homeless individuals. See the “Methods” section for more information.

e

Usual GP is a proxy for “patient family physician,” defined as having at least 2 consultations with the same GP or with at least 2 GP working in the same family medicine group. Family medicine groups provide patient registration and greater access and continuity of care. Usual psychiatrist was defined as one who followed a given patient in outpatient care at least twice. Alternatively, patients who made only one outpatient consultation with a psychiatrist had to have consulted their GP at least twice, which was considered a proxy for collaborative care (see references in the “Methods” section).

f

Continuity of physician care was measured by the Usual Provider Continuity Index describing the proportion of consultations with the usual GP or psychiatrist out of all GP and psychiatrists consulted in outpatient care, including consultations in walk-in clinics. A score of ≥0.8 is considered high continuity of care (see references in the “Methods” section).

g

Community healthcare centers mainly provide psychosocial interventions delivered through multidisciplinary teams (e.g., social workers, nurses, and psychologists). These services are complementary to the care provided by GP, and both are primary care (or first-line) services.

h

Treatment programs offered in addiction treatment centers included: medical activities (e.g., substitution treatment), specialized addiction services either internal (e.g., detoxification treatment) or external (e.g., counselling, reintegration) and brief treatment (see the “Methods” section).

Patients with alcohol-related disorders only and those with SRD-chronic physical illnesses, respectively, had a 1.75 and 5.18 times higher risk of death from a physical illness compared to patients with other SRD or those without chronic physical illness (Table 2). Compared to women, men were 82% more likely to die from physical illness and 66% more likely to die of accidental/intentional causes. Patients living in more materially deprived areas had a 2.40 times higher risk of death from physical illness and 1.65 times higher risk of accidental/intentional death, while those in socially deprived areas had a 1.33 times higher risk of death from physical illness and 3.23 times higher risk of accidental/intentional death. Patients 50+ years of age or unemployed had a 1.42 times or 88% higher risk of death from a physical illness compared with younger or worker/student patients.

Table 2.

Predictors of Death From Physical Illness or Accidental/Intentional Causes Among Patients with Substance-Related Disorders – Multivariable Logistic Regression (Reference Group: no Death).

Death from physical illness* Death from accidental or intentional causes*
RRR P-value 95% CI RRR P-value 95% CI
Patient clinical characteristics (measured from April 1, 2012, to March 31, 2016, to time of death, or other if specified)
Alcohol-related disorders only vs. other SRD 2.75 <0.001 2.01 3.76 1.26 0.241 0.86 1.86
Chronic physical illnesses a 6.18 <0.001 3.50 10.90 1.21 0.254 0.87 1.67
Patient sociodemographic characteristics (measured in the year of death, or other if specified) b
Men versus Women 1.82 <0.001 1.31 2.52 1.66 0.003 1.20 2.32
Age 50 years or older versus under 50 years old 2.42 <0.001 1.80 3.26 0.94 0.758 0.65 1.36
Principal occupation: unemployed or retired (vs. student or worker) 1.88 0.001 1.28 2.77 1.27 0.151 0.92 1.77
More materially deprived areas (4, 5 or not assigned) c 3.40 <0.001 2.34 4.94 2.65 <0.001 1.83 3.82
More socially deprived areas (4, 5 or not assigned) c 2.33 <0.001 1.60 3.39 4.23 <0.001 2.65 6.76
Patient service use (measured within 12 months prior to death) b
Number of consultations with usual psychiatrist d
 1–3 versus 0 0.50 0.006 0.31 0.82 1.11 0.620 0.73 1.70
 4+ versus 0 0.40 <0.001 0.25 0.64 0.68 0.095 0.43 1.07
Number of interventions provided through any treatment program in addiction treatment centres e
 1–3 versus 0 0.52 0.001 0.35 0.77 1.04 0.824 0.71 1.53
 4+ versus 0 0.47 <0.001 0.34 0.63 0.74 0.074 0.53 1.03
Number of ED use for any medical reason
 1–3 versus 0 1.90 0.007 1.19 3.02 1.97 0.001 1.34 2.91
 4+ versus 0 4.67 <0.001 2.80 7.77 4.09 <0.001 2.53 6.62
Hospitalization for any medical reason 9.22 <0.001 6.26 13.56 2.58 <0.001 1.83 3.62

Note. SRD = substance-related disorders; RRR = relative risk ratio; CI = confidence interval; ED = emergency department.

*Death was measured from April 1, 2013, to March 31, 2016, a 3-year period; financial year, April 1–March 31.

a

See note b below Table 1.

b

See note c below Table 1.

c

See note d below Table 1.

d

See note e below Table 1.

e

See note h below Table 1.

Compared to patients with no psychiatric consultations, those who received 1 to 3 or 4+ psychiatric consultations were 50% and 60% less likely to die from physical illness. Receiving 4+ consultations suggested a 32% statistical trend toward a lower risk of accidental/intentional death. Patients who received 1 to 3 or 4+ interventions in addiction treatment centers were 48% or 53% less likely to die from physical illness than those without SRD interventions, while receiving 4+ interventions also related to a 26% statistical trend toward a lower risk of accidental/intentional death. Patients who used ED 1 to 3 times and frequent ED users had a 90% or 3.67 times higher risk of death from physical illness, as well as 3.09 times (97%) higher risk of accidental/intentional death than those who did not use ED. Previously hospitalized patients were at 8.22 times higher risk of death from physical illness and at 1.58 times more risk for accidental/intentional death.

Discussion

This study identified patient sociodemographic, clinical, and service use characteristics that predicted death from physical illness or accidental/intentional causes. The study death rate from 2013−2014 to 2015−2016 (2.4%) was higher than in the Quebec general population for this period, with an average near 0.6%/year. 55 The findings confirmed the first hypothesis that severe health conditions would be the strongest predictors of death from physical illness. The risk of death for patients previously hospitalized, reporting SRD-chronic physical illnesses, with previous frequent ED use, or with alcohol-related disorders only were 8, 5, 4, and 2 times greater than that of patients without these conditions. SRD, and alcohol-related disorders more specifically, are known to contribute to the development of several chronic physical illnesses like cancer, liver, and cardiovascular diseases 56 often associated with death.10,57 These patients usually require hospitalization as well, testifying to the severity of these health conditions. Hospitalization was the study variable most strongly linked to death from physical illness, with higher risk also identified among patients 50+ years old. That older age increases both the risk of chronic physical illnesses and death is well-known. 23

Being a frequent ED user is a key indicator of adverse outcomes for patients.58,59 Frequent ED use often translates into inappropriate provision or quality of outpatient care for patients with diverse needs. 60 Studies show that patients with SRD have some of the highest rates of ED use and hospitalization, which might be explained by their usually low rates of outpatient service use 61 and high dropout from services. 62 Roughly half of the patients in this study lacked a usual physician, high continuity of physician care, and had received no treatment from addiction treatment centers or community healthcare centers in the 12-month follow-up period before death. Considering that three-quarters of patients had cooccurring MD, nearly half with chronic physical illnesses, and more than one-third with SRD-MD-chronic physical illnesses, this low level of outpatient service use might explain the high study rates of frequent ED use and hospitalization. Both adverse outcomes, frequent ED use and hospitalization, predicted accidental/intentional death and death from physical illness among hospitalized patients, whose risk for accidental/intentional death, however, was 4 times lower than death from physical illness.

Accidental/intentional death was explained more by sociodemographic characteristics than other patient characteristics. Notably, patients living in more socially deprived areas were twice as likely to die of accidental/intentional causes than from physical illness, making social deprivation the strongest predictor of accidental/intentional death. It is possible that patients without social support were at higher risk for suicide or self-harm and were possibly more victimized by aggression or prone to risky behaviours leading to accidental death. By contrast, a good social network might encourage patients to seek help for SRD and to complete treatment. 63 Living in more materially deprived areas was also strongly associated with both death from physical illness and accidental/intentional death. Poverty has often been associated in previous research with a greater risk of death, due to poor lifestyle habits leading to more chronic physical illnesses and associated difficulties.64,65 However, in this study being unemployed or retired was associated with death from physical illness only, perhaps due to the more severe health conditions and older age of this group that may prevent them to work. Finally, being male increases the risk of both death from physical illness and accidental/intentional death. Men usually seek less help than women 66 and tend to use specialized services rather than primary care, 67 as they often seek help as a last resort when their health conditions become intolerable 68 —another possible explanation for the higher risk of death. However, the literature shows mixed results on risk of death according to sex, with studies finding higher risk among women,69,70 higher among men, 56 or no differences between them. 71

The second study hypothesis, which states that more adequate outpatient service use would protect against both death from physical illness and accidental/intentional causes, was partially confirmed. Findings showed that receiving at least 1 intervention from a usual psychiatrist or addiction treatment center protected against death from physical illness. However, the findings for accidental/intentional death reflected only statistical trends. Patients with more complex health problems were perhaps more likely to adhere to their psychiatric or SRD treatments, which may have helped reduce their risk of death from physical illness. Moreover, outpatient services provided by hospital psychosocial teams, crisis or suicide prevention centers might have safeguarded patients against the risk of death by accidental/intentional causes better than physician care or services for SRD, but this data was not available to the study. The results might also reflect the uncaptured severity or poor self-management of health conditions. As well, the study found small associations between a higher intensity of care provided to patients and death. Study results on the appropriate intensity of care for patients with SRD are mixed 72 and may fluctuate according to patient needs. The intensity of services is only 1 dimension of quality of care, 73 while adequacy of services for responding to the diversity of patient needs and deployment of best practices may be more key for protecting patients against adverse events. In this study, both the provision of high continuity physician care and care from a usual GP did not protect against death. According to the literature, GP greatly underdetect and undertreat patients with SRD and cooccurring SRD-MD, as they are often uncomfortable with these patients.74,75 This might explain the finding that these two variables did not protect against death.

Limitations

First, SRD other than alcohol only were combined in a single category. The database did not make it possible to identify specific SRD (e.g., opioid-related disorders) that could be more strongly associated with death from physical illness or accidental/intentional death. Second, it was not possible to distinguish accidental from intentional death in the database. These categories were thus integrated, even though they may have been related to distinct predictors. Third, services like crisis centers, suicide prevention centers, Alcoholics Anonymous, or hospital psychosocial care that could help prevent death were not included in the study database. Fourth, a longer follow-up period might have helped better identify patient characteristics related to death. Finally, results may not be generalizable to patients with SRD not using addiction treatment centers, or to countries without public healthcare insurance for this population.

Conclusion

This study found that the severity of patient conditions, mainly among hospitalized patients, those with SRD-chronic physical illnesses, alcohol-related disorders, or more materially deprived, most strongly predicted death from physical illness. Patient sociodemographic characteristics were more strongly linked to accidental/intentional death, especially for those living in more socially deprived areas. However, previous hospitalization also predicted accidental/intentional death. Being a frequent ED user predicted both deaths from physical illness and accidental/intentional causes, suggesting that outpatient care was highly inappropriate for responding to patients with diverse needs. Only specialized SRD and psychiatric care decreased the risk of death from physical illness. However, study patients used few outpatient services overall despite dealing with multiple health issues. Outpatient services could thus be greatly improved by increasing outreach and motivational interventions, and in ED and hospital units through particular attention to screening, brief intervention, and treatment referral including information on and prevention of risky behaviours, especially for patients at high risk of accidental/intentional death. Patients with more severe health conditions, those materially deprived, and especially older men at higher risk of death from physical illness could benefit from programs like assertive community treatment or intensive case management that respond well to patient needs. Collaborative care between SRD, physical and mental health services, including increased training for GP on treatment for patients with SRD, could further promote improved overall care, more specifically for patients at high risk of death from physical illness.

Acknowledgements

We gratefully acknowledge the support of the Substance Use and Addiction Program of Health Canada, the Quebec Ministère de la santé et des services sociaux (Ministry of Health and Social Services0 and the University Institute on Addictions (IUD), as well as the Quebec Network on Suicide, Mood Disorders and Associated Disorders.

Appendix

Appendix 1.

Codes for SRD, MD, Chronic Physical Illnesses, and Death According to the ICD-9 and ICD-10.

Diagnoses ICD-9 ICD-10-CA
SRD a
Alcohol-related disorders 3030*, 3039*, 3050* (alcohol abuse or dependence); 2910*, 2918* (alcohol withdrawal), 2911*-2915*, 2919*, 3575, 4255, 5353, 5710-5713 (alcohol-induced disorders); 9800, 9801, 9808, 9809 (alcohol intoxication) F101*, F102* (alcohol abuse or dependence); F103, F104* (alcohol withdrawal); F105–F109, K700*-K704*, K709*, G621*, I426, K292*, K852, K860, E244, G312, G721, O354 (alcohol-induced disorders); F100*, T510, T511*, T518, T519 (alcohol intoxication)
Cannabis-related disorder 3043, 3052 (cannabis abuse or dependence) F121, F122 (cannabis abuse or dependence); F123–F129 (cannabis-induced disorders); F120, T407 (cannabis intoxication)
Other drug-related disorders than cannabis 3040-3042, 3044-3049, 3053-3057, 3059 (drug abuse or dependence); 292.0 (drug withdrawal); 2921, 2922, 2928, 2929 (drug-induced disorders); 9650, 9658, 9670, 9676, 9678, 9679, 9694-9699, 9708, 9820, 9828 (drug intoxication) F111, F131, F141, F151, F161, F181, F191, F112, F132, F142, F152, F162, F182, F192 (drug abuse or dependence); F113–F114, F133–F134, F143–F144, F153–F154, F163–F164, F183–F184, F193–F194 (drug withdrawal) F115–F119, F135–F139, F145–F149, F155–F159, F165–F169, F185–F189, F195–F199 (drug-induced disorders); F110, F130, F140, F150, F160, F180, F190, T400–T406, T408, T409, T423, T424, T426, T427, T435, T436, T438, T439, T509, T528, T529 (drug intoxication)
MD a
Serious MD
Schizophrenia spectrum and other psychotic disorders 295* (schizophrenic disorders); 297* (paranoid states); 298* (other nonorganic psychoses) F20* (schizophrenic disorders); F22* (persistent delusional disorders); F23 (acute and transient psychotic disorders); F24* (induced delusional disorder); F25* (schizoaffective disorders); F28* (other psychotic disorder not due to a substance or known physiological condition); F29* (unspecified psychosis not due to a substance or known physiological condition); F448 (other dissociative and conversion disorders); F481 (depersonalization - derealization syndrome)
Bipolar disorders 2960-2966 (manic disorders); 2968 (other affective psychoses); 2969 (unspecified affective psychoses) F300–F302, F308, F309 (manic episode); F310–F317, F318, 319 (bipolar episode)
Personality disorders 3010 (paranoid personality disorder); 3011 (affective personality disorder); 3012 (schizoid disorder); 3013, 3014 (obsessive-compulsive personality disorder); 3015 (histrionic personality disorder); 3016 (dependent personality disorder); 3017 (antisocial personality disorder); 3018 (other personality disorders); 3019 (unspecified personality disorder) F600 (paranoid personality disorder); F61 (mixed and other personality disorders); F340 (cyclothymic disorder); F341 (dysthymic disorder); F601 (schizoid personality); F603 (borderline personality disorder); F605 (obsessive-compulsive personality disorder); F604 (histrionic personality disorder); F607 (dependent personality disorder); F602 (antisocial personality disorder); F609 (unspecified personality disorder); F21 (schizotypal personality); F606 (avoidant personality disorder); F608 (other specified personality disorders); F681 (factitious disorder); F688 (other specified disorders of adult personality and behaviour); F69 (unspecified disorder of adult personality and behaviour)
Common MD
Depressive disorders 3004 (neurotic depression)*; 311, 3119* (depressive disorder, not elsewhere classified) F320- F323 (major depressive disorder, single episode); F328 (other depressive episodes); F329 (depressive episode, unspecified); F330–F334 (major depressive disorder, recurrent); F338 (other recurrent depressive disorders); F339 (recurrent depressive disorder, unspecified); F348 (other persistent mood [affective] disorders); F380, F381 (persistent mood [affective] disorder, unspecified); F388 (other specified mood [affective] disorders); F39 (unspecified mood [affective] disorders); F412* (mixed anxiety and depressive disorder)*
Anxiety disorders 300 (except 3004); 3000 (anxiety states); 3002 (phobic anxiety disorders); 3003 (obsessive-compulsive disorder); 3001 (hysteria); 3006 (other anxiety disorder); 313 (disturbance of emotions specific to childhood and adolescence) F40 (phobic anxiety disorders); F41(other anxiety disorders); F42 (obsessive-compulsive disorder); F45 (somatoform disorders); F48 (other neurotic disorders); F93, F94 (disturbance of emotions specific to childhood and adolescence)
Adjustment disorders 3090 (brief depressive reaction); 3092 (adjustment reaction with predominant disturbance of other emotions, include: abnormal separation anxiety); 3093 (adjustment reaction with predominant disturbance of conduct); 3094 (adjustment reaction with predominant disturbance of other emotions and conduct); 3098 (other specified adjustment reactions); 3099 (unspecified adjustment reaction) F430 (acute stress reaction); F431 (post-traumatic stress disorder); F432 (adjustment disorders); F438 (other reactions to severe stress); F439 (reaction to severe stress, unspecified)
Other MD 314 (attention-deficit/hyperactivity disorder); 2930, 2931 (transient organic psychotic conditions); 2940, 2941 (other organic psychotic conditions); 2990, 2991*, 2998, 2999 (pervasive developmental disorders); 290, 2941, 3310, 3312 (dementia); 3020-3029 (sexual deviations and disorders); 3070-3079 (special symptoms or syndromes, not elsewhere classified include anorexia nervosa, tics); 312 (disturbance of conduct, not elsewhere classified); 3150-3159 (specific delays in development); 316 (psychic factors associated with diseases classified elsewhere); 317-318 (mental retardation) F900; F901; F908; F909 (attention deficit/hyperactivity disorder); F060–F069 (other MD due to known physiological condition); F840, F841, F842, F843, F844, F845 (pervasive developmental disorders); F00x-F03, F051, G30, G311(dementia); F500–F502 (eating disorders); F520–F529 (sexual dysfunction, not caused by organic disorder or disease); F510–F515 (nonorganic sleep disorders); F950–F952, F958, F959 (tic disorders); F980–F986, F988, F989 (other behavioral and emotional disorders with onset usually occurring in childhood and adolescence); F630–F633, F638, F639 (habit and impulse disorders); F70–73, F78, F79 (mental retardation)
Suicide attempt a , b X60–Y09, Y870, Y871, Y35–Y36, Y890, Y891
Chronic physical illnesses a , c
Renal failure 4030, 4031, 4039, 4040, 4041, 4049, 585, 586, 5880, V420, V451, V56 I120, I131, N18, N19, N250, Z49, Z940, Z992
Cerebrovascular illnesses 430–438 G45, G46, I60–I69
Neurological illnesses 3319, 3320, 3321, 3334, 3335, 3339, 334–335, 3362, 340, 341, 345, 3481, 3483, 7803, 7843 G10–G12, G13, G20, G21–G22, G254, G255, G312, G318, G319, G32, G35, G36, G37, G40, G41, G931, G934, R470, R56
Endocrine illnesses (hypothyroidism; fluid electrolyte disorders and obesity) 2409, 243, 244, 2461, 2468; 2536, 276; 2780 E00, E01, E02, E03, E890; E222, E86, E87; E66
Any tumour with or without metastasis (solid tumour without metastasis; lymphoma) 140–172, 174, 175, 179–195, 196–199; 200, 201, 202, 2030, 2386, 2733 C00–C26, C30–C34, C37–C41, C43, C45–C58, C60–C76, C77–C79, C80; C81–C85, C88, C900, C902, C96
Chronic pulmonary illnesses 490–505, 5064, 5081, 5088 I278, I279, J40–J47, J60–J64, J65, J66, J67, J684, J701, J703
Diabetes complicated and uncomplicated 2500–2502, 2503; 2504–2509 E102–E108, E112–E118, E132–E138, E142–E148; E100, E101, E109, E110, E111, E119, E130, E131, E139, E140, E141, E149
Cardiovascular illnesses (congestive heart failure; cardiac arrhythmias; valvular illnesses; peripheral vascular illnesses; myocardial infarction; hypertension and pulmonary circulation illnesses) 4021, 4041, 428; 4260, 4267, 4269,4270–4274,4276–4279, 7850, V450, V533; 394–397, 424,7463–7466, V422, V433; 093, 440, 441, 4431– 4439, 4471, 5571, 5579, V434; 4109, 4129; 4010, 4011, 4019, 4020, 4021, 4029, 4050, 405,4051, 4059, 4372; 4150, 4151, 416; 4170, 4178, 4179 I099, I110, I130, I132, I255, I420, I425–I429, I43, I50, P290; I441–I443, I456, I459, I47–I49, R000, R001, R008, T821, Z450, Z950; A520, I70–I72, I730, I731, I738, I739, I771, I790, K551, K558, K559, Z958, Z959; I05–I08, I091, I098, I34–I39, Q230–Q233, Q238, Q239, Z952, Z953, Z954I210–I214, I219, I220, I221, I228, I229, I252; I101, I100, I11, I1500, I1501, I1510, I1511, I1521, I1581, I1590, I1591, I674; I26, I27, I280, I288, I289
Other chronic physical illness categories (blood loss anaemia; ulcer illnesses; liver illnesses; AIDS/HIV; rheumatoid arthritis/collagen vascular illnesses, coagulopathy; weight loss, paralysis; deficiency anemia) 2800, 2809; 286, 2871, 2873–2875; 5317, 5319, 5327, 5329, 5337, 5339, 5347, 5349; 0702, 0703, 0704, 0705, 4560–4562, 5723, 5728, 5733, 5734, 5739, V427; 042–044; 1361, 446; 7010, 7100–7104, 7105, 7108, 7109, 7112, 714, 7193, 720, 725, 7285, 7288, 7293; 260–263, 7832, 7994; 3341, 342, 343, 3440–3446, 3448, 3449; 2801, 2809, 281, 2859 D500; K257, K259, K267, K269, K277, K279, K287, K289; B20–B24; D65–D68, D691, D693–D696; B18, I85, I864, I982, K700- K703, K709 K711, K713–K715, K716, K717, K721, K729, K73, K74, K754, K760, K761, K763, K764, K765, K766, K768, K769, Z944; L900, L940, L941, L943, M05, M06, M08, M120, M123, M30, M31, M32–M35, M45, M460, M461, M468, M469; G041, G114, G80, G81, G82, G83; E40–E46, R634, R64, D51–D53, D63, D649; D501, D508; D509
Causes of death d
Death from physical illness
Infections 0–139 A00–A99, B00–B99, U04
Cancers 140–239 C00–C99, D00–D49
Other physical diseases
 Endocrine, nutritional, and metabolic diseases 240–279 E00–E99
 Diseases of the nervous system 320–294, 310 F00–F09, G00–G99, H00–H99
 Diseases of the circulatory system 390–459 I00–I99
 Diseases of the respiratory system 460–519 J00–J99
 Diseases of the digestive system 520–579 K00–K99
 Other diseases and symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified All remaining codes not listed, except MD All remaining codes not listed, except MD
Accidental/intentional death
Injury, poisoning, and certain other consequences of external causes 800–999 S00–S99, T00–T99, V00–V99, W00–W99, X00–X99 [except X60–X84], Y00–Y99 [except Y870]
Suicide X60–X84, Y870

Note. SRD = substance-related disorders; ICD-9 = International Classification of Diseases, Ninth Revision; ICD-10-CA = International Classification of Diseases, Tenth Revision, Canada; MD = mental disorders.

a

All diagnoses identified in RAMQ (Régie de l’assurance maladie du Québec, Physician Claims database) for the full study period were based on the International Classification of Diseases Ninth Revision (ICD-9), which included a 4-digit code, from financial year: April 1 to March 31. The Canadian Tenth Revision (ICD-10-CA) was used in MED-ECHO (Maintenance et exploitation des données pour l’étude de la clientèle hospitalière, Hospital Inpatient and Day Surgery database) in 2006–2007+ and in BDCU (Banque de données communes des urgencies, emergency department (ED) database). Diagnoses related to all the above databases were considered, and all data was integrated each year, for each patient. MED-ECHO is the only database that includes several diagnoses: principal diagnosis and numerous secondary diagnoses. In the databases used in this study, MD were considered only as principal diagnoses, but SRD as both principal and secondary diagnoses, considering that SRD is often underdiagnosed.

b

Diagnostic codes for a suicide attempt were registered in the MED-ECHO database. ED use for reasons of suicide ideation or attempt was also reported by ED triage nurses and registered in the BDCU database; as they are not diagnostic codes, they were not reported in this table.

c

The list of chronic physical illnesses is based on an adapted and validated version of the Elixhauser Comorbidity Index, integrating the Charlson Index, which consists of 32 major categories of physical illnesses (see reference in the “Methods” section). In this list of chronic physical illnesses, three categories of MD and two of SRD (identified with an asterisk (*)) were also included in the list of MD-SRD, thus appearing twice.

d

Causes of death were those identified in the Fichier des décès du Registre des évènements démographiques (RED, Vital Statistics Death database).

Footnotes

Availability of Data: In accordance with the applicable ethics regulations for the province of Quebec, the principal investigator is responsible for keeping data confidential.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Substance Use and Addiction Program of Health Canada, Québec Ministère de la santé et des services sociaux (Ministry of Health and Social Services), grant numbers 8400886 and 8400993.

ORCID iD: Marie-Josée Fleury https://orcid.org/0000-0002-4743-8611

Christophe Huỳnh PhDhttps://orcid.org/0000-0003-4345-9463

References

  • 1.Bista S, Nathan S, Rawstorne P, et al. Mortality among young people seeking residential treatment for problematic drug and alcohol use: a data linkage study. Drug Alcohol Depend. 2021;228:109030. [DOI] [PubMed] [Google Scholar]
  • 2.Whiteford H, Ferrari A, Degenhardt L. Global burden of disease studies: implications for mental and substance use disorders. Health Aff (Millwood). 2016;35(6):1114-1120. [DOI] [PubMed] [Google Scholar]
  • 3.Iturralde E, Slama N, Kline-Simon AH, Young-Wolff KC, Mordecai D, Sterling SA. Premature mortality associated with severe mental illness or substance use disorder in an integrated health care system. Gen Hosp Psychiatry. 2021;68:1-6. [DOI] [PubMed] [Google Scholar]
  • 4.Westman J, Wahlbeck K, Laursen TM, et al. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiatr Scand. 2015;131(4):297-306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.EMCDAA. Mortality among drug users in Europe: new and old challenges for public health. European Monitoring Centre for Drugs and Drug Addiction; 2015.
  • 6.Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32-51. [DOI] [PubMed] [Google Scholar]
  • 7.Peacock A, Tran LT, Larney S, et al. All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis. Addiction. 2021;116(4):725-742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Arendt M, Munk-Jorgensen P, Sher L, Jensen SO. Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abuse Treat. 2013;44(4):400-406. [DOI] [PubMed] [Google Scholar]
  • 9.Askgaard G, Leon DA, Deleuran T, Tolstrup JS. Hospital admissions and mortality in the 15 years after a first-time hospital contact with an alcohol problem: a prospective cohort study using the entire Danish population. Int J Epidemiol. 2020;49(1):94-102. [DOI] [PubMed] [Google Scholar]
  • 10.Roerecke M, Rehm J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(3):906-919. [DOI] [PubMed] [Google Scholar]
  • 11.Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the global burden of disease study 2010. PLoS One. 2014;9(4):e91936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lynch FL, Peterson EL, Lu CY, et al. Substance use disorders and risk of suicide in a general US population: a case control study. Addict Sci Clin Pract. 2020;15(1):14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Center for Behavioral Health Statistics and Quality. 2016 national survey on drug use and health: detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2017. [Google Scholar]
  • 14.Ashford RD, Brown AM, Curtis B. Systemic barriers in substance use disorder treatment: a prospective qualitative study of professionals in the field. Drug Alcohol Depend. 2018;189:62-69. [DOI] [PubMed] [Google Scholar]
  • 15.Bech AB, Clausen T, Waal H, Saltyte Benth J, Skeie I. Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study. BMC Health Serv Res. 2019;19(1):440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hayes RD, Chang CK, Fernandes A, et al. Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service. Drug Alcohol Depend. 2011;118(1):56-61. [DOI] [PubMed] [Google Scholar]
  • 17.Krawczyk N, Eisenberg M, Schneider KE, et al. Predictors of overdose death among high-risk emergency department patients with substance-related encounters: a data linkage cohort study. Ann Emerg Med. 2020;75(1):1-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fridell M, Backstrom M, Hesse M, Krantz P, Perrin S, Nyhlen A. Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up. BMC Psychiatry. 2019;19(1):150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fine DR, Yu L, Triant VA, Baggett TP, Metlay JP. Baseline factors associated with mortality in patients who engaged in buprenorphine treatment for opioid use disorder: a cohort study. J Gen Intern Med. 2020;35(8):2375-2382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hser YI, Mooney LJ, Saxon AJ, et al. High mortality among patients with opioid use disorder in a large healthcare system. J Addict Med. 2017;11(4):315-319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. Br Med J. 2017;357:j1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sanvisens A, Hernandez-Rubio A, Zuluaga P, et al. Long-term outcomes of patients with cocaine use disorder: a 18-years addiction cohort study. Front Pharmacol. 2021;12:625610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Scott CK, Dennis ML, Laudet A, Funk RR, Simeone RS. Surviving drug addiction: the effect of treatment and abstinence on mortality. Am J Public Health. 2011;101(4):737-744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Thylstrup B, Seid AK, Tjagvad C, Hesse M. Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorder. Drug Alcohol Depend. 2020;206:107714. [DOI] [PubMed] [Google Scholar]
  • 25.Hesse M, Thylstrup B, Seid AK, Skogen JC. Suicide among people treated for drug use disorders: a Danish national record-linkage study. BMC Public Health. 2020;20(1):146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rizk MM, Herzog S, Dugad S, Stanley B. Suicide risk and addiction: the impact of alcohol and opioid use disorders. Curr Addict Rep. 2021;8(2):194-207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yuodelis-Flores C, Ries RK. Addiction and suicide: a review. Am J Addict. 2015;24(2):98-104. [DOI] [PubMed] [Google Scholar]
  • 28.Association des centres de réadaptation en dépendance du Québec. Rapport annuel 2013–2014. Baliser l’action. Protéger l’offre de service en dépendance. Montréal: Association des centres de réadaptation en dépendance; 2014. [Google Scholar]
  • 29.Régie de l’assurance maladie du Québec. Rapport annuel de gestion, 2016–2017. Québec: Régie de l’assurance maladie du Québec; 2017. [Google Scholar]
  • 30.Bergeron J, Landry M, Ishak A, Vaugeois P, Trepanier M. Validation d’un instrument d’évaluation de la gravité des problèmes reliés à la consommation de drogues et d’alcool. L’indice de Gravité d’une Toxicomanie. Montréal: Cahier de recherche du RISQ, 1992. [Google Scholar]
  • 31.McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. JJ Nerv Ment Dis. 1980;168(1):26-33. [DOI] [PubMed] [Google Scholar]
  • 32.Dennis ML, White M, Titus J, Unsicker J. Global appaisal of individual needs (GAIN): Administration guide for the GAIN and related measures (Version 5). Bloomington, IL: Chestnut Health Systems; 2008. [Google Scholar]
  • 33.Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020. [Google Scholar]
  • 34.Saha TD, Grant BF, Chou SP, Kerridge BT, Pickering RP, Ruan WJ. Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: sociodemographic characteristics, severity, and psychopathology. Drug Alcohol Depend. 2018;187:261-269. [DOI] [PubMed] [Google Scholar]
  • 35.Simard M, Dubé M, Myles G, Sirois C. La prévalence de la multimorbidité au Québec: Portrait pour l’année 2016–2017. Québec: Institut national de santé publique du Québec; 2019. [Google Scholar]
  • 36.Pulkkinen L, Kolko K. Human development from middle childhood to middle adulthood: Growing up to be middle-aged. London, UK: Routledge, Taylor & Francis Group; 2017. [Google Scholar]
  • 37.Huynh C, Caron J, Pelletier M, Liu A, Fleury MJ. A developmental perspective in mental health services use among adults with mental disorders. J Behav Health Serv Res. 2018;45(3):389-420. [DOI] [PubMed] [Google Scholar]
  • 38.Martin LG, Freedman VA, Schoeni RF, Andreski PM. Trends in disability and related chronic conditions among people ages fifty to sixty-four. Health Aff (Millwood). 2010;29(4):725-731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Brown RT, Diaz-Ramirez LG, Boscardin WJ, Lee SJ, Steinman MA. Functional impairment and decline in middle age: a cohort study. Ann Intern Med. 2017;167(11):761-768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pampalon R, Hamel D, Gamache P, Raymond G. A deprivation index for health planning in Canada. Chronic Dis Can. 2009;29(4):178-191. [PubMed] [Google Scholar]
  • 41.Dreiher J, Comaneshter DS, Rosenbluth Y, Battat E, Bitterman H, Cohen AD. The association between continuity of care in the community and health outcomes: a population-based study. Isr J Health Policy Res. 2012;1(1):21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Menear M, Duhoux A, Roberge P, Fournier L. Primary care practice characteristics associated with the quality of care received by patients with depression and comorbid chronic conditions. Gen Hosp Psychiatry. 2014;36(3):302-309. [DOI] [PubMed] [Google Scholar]
  • 43.Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92(1):92-98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Young AS, Klap R, Shoai R, Wells KB. Persistent depression and anxiety in the United States: prevalence and quality of care. Psychiatr Serv. 2008;59(12):1391-1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Breslau N, Reeb KG. Continuity of care in a university-based practice. J Med Educ. 1975;50(10):965-969. [DOI] [PubMed] [Google Scholar]
  • 46.Brennan JJ, Chan TC, Hsia RY, Wilson MP, Castillo EM. Emergency department utilization among frequent users with psychiatric visits. Acad Emerg Med. 2014;21(9):1015-1022. [DOI] [PubMed] [Google Scholar]
  • 47.LaCalle E, Rabin E. Frequent users of emergency departments: the myths, the data, and the policy implications. Ann Emerg Med. 2010;56(1):42-48. [DOI] [PubMed] [Google Scholar]
  • 48.Bartlett JW, Harel O, Carpenter JR. Asymptotically unbiased estimation of exposure odds ratios in complete records logistic regression. Am J Epidemiol. 2015;182(8):730-736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Maas CJ, Hoss JJ. Sufficient sample sizes for multilevel modeling. Methodology (Gott). 2005;1:56-92. [Google Scholar]
  • 50.Paccagnella O. Sample size and accuracy of estimates in multilevel models: new simulation results. Methodology (Gott). 2011;7:111-120. [Google Scholar]
  • 51.Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-137. [DOI] [PubMed] [Google Scholar]
  • 52.Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. Proceedings of the 2nd international symposium on information theory. Budapest: Akademiai Kiado; 1973, pp. 267-281. [Google Scholar]
  • 53.Hair J, Black WC, Babin BJ, Anderson RE. Multivariate data analysis. 7th ed. Upper Saddle River, NJ: Pearson Education International; 2001. [Google Scholar]
  • 54.StataCorp. Stata statistical software: Release 17. College Station, TX: StataCorp LLC; 2021. [Google Scholar]
  • 55.Fleury-Payeur F, Azeredo AC. La mortalité et l’espérance de vie au Québec en 2020. Bulletin socidémographique. Institut de la Statistique du Québec. 2021;25(2):1-6. [Google Scholar]
  • 56.Nyhlen A, Fridell M, Hesse M, Krantz P. Causes of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970–2006. J Forensic Leg Med. 2011;18(2):66-72. [DOI] [PubMed] [Google Scholar]
  • 57.Hjemsaeter AJ, Bramness JG, Drake R, et al. Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study. BMC Psychiatry. 2019;19(1):101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Fuller RL, Atkinson G, McCullough EC, Hughes JS. Hospital readmission rates: the impacts of age, payer, and mental health diagnoses. J Ambul Care Manage. 2013;36(2):147-155. [DOI] [PubMed] [Google Scholar]
  • 59.Sorup CM, Jacobsen P, Forberg JL. Evaluation of emergency department performance—a systematic review on recommended performance and quality-in-care measures. Scand J Trauma Resusc Emerg Med. 2013;21(1):62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Davies S, Schultz E, Raven M, et al. Development and validation of the agency for healthcare research and quality measures of potentially preventable emergency department (ED) visits: the ED prevention quality indicators for general health conditions. Health Serv Res. 2017;52(5):1667-1684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Urbanoski K, Inglis D, Veldhuizen S. Service use and unmet needs for substance use and mental disorders in Canada. Can J Psychiatry. 2017;62(8):551-559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjaern T. Predictors of dropout from inpatient substance use treatment: a prospective cohort study. Subst Abuse. 2018;12:1178221818760551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Mutschler J, Eifler S, Dirican G, et al. Functional social support within a medical supervised outpatient treatment program. Am J Drug Alcohol Abuse. 2013;39(1):44-49. [DOI] [PubMed] [Google Scholar]
  • 64.Aldridge RW, Story A, Hwang SW, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241-250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Compton MT, Shim RS. The social determinants of mental health. Focus. 2015;13:419-425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Sagar-Ouriaghli I, Godfrey E, Bridge L, Meade L, Brown JSL. Improving mental health service utilization among men: a systematic review and synthesis of behavior change techniques within interventions targeting help-seeking. Am J Mens Health. 2019;13(3):1557988319857009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ayangbayi T, Okunade A, Karakus M, Nianogo T. Characteristics of hospital emergency room visits for mental and substance use disorders. Psychiatr Serv. 2017;68(4):408-410. [DOI] [PubMed] [Google Scholar]
  • 68.Fleury MJ, Grenier G, Bamvita JM, Perreault M, Caron J. Variables associated with perceived unmet need for mental health care in a Canadian epidemiologic catchment area. Psychiatr Serv. 2016;67(1):78-85. [DOI] [PubMed] [Google Scholar]
  • 69.Evans E, Kelleghan A, Li L, et al. Gender differences in mortality among treated opioid dependent patients. Drug Alcohol Depend. 2015;155:228-235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(2):102-123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Rogers RG, Boardman JD, Pendergast PM, Lawrence EM. Drinking problems and mortality risk in the United States. Drug Alcohol Depend. 2015;151:38-46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Beaulieu M, Tremblay J, Baudry C, Pearson J, Bertrand K. A systematic review and meta-analysis of the efficacy of the long-term treatment and support of substance use disorders. Soc Sci Med. 2021;285:114289. [DOI] [PubMed] [Google Scholar]
  • 73.Canadian Institute for Health Information. A performance measurement framework for the Canadian Health System, Updated November 2013. Ottawa: Canadian Institute for Health Information; 2013. [Google Scholar]
  • 74.Fleury MJ, Grenier G, Gentil L, Roberge P. Deployment of the consultation-liaison model in adult and child-adolescent psychiatry and its impact on improving mental health treatment. BMC Fam Pract. 2021;22(1):82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.O’Malley DM, Abraham CM, Lee HS, et al. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators. Fam Pract. 2022;39(2):282-291. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie are provided here courtesy of SAGE Publications

RESOURCES